WuXi PharmaTech Cayman (NYSE:WX), a company whose shares are moving quickly, is trading 1.5% lower to $15.51. The Dow Jones Industrial Average is now trading fractionally lower to 12,925 and the S&P is trading 0.2% higher to 1,405.
Over the past year, WuXi PharmaTech Cayman has traded in a range of $11.14 to $17.08 and is now at $15.51, 39% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.2%.
WuXi PharmaTech Cayman (NYSE:WX) has potential upside of 22.8% based on a current price of $15.51 and analysts' consensus price target of $19.05. The stock should discover initial support at its 50-day moving average (MA) of $15.29 and subsequent support at its 200-day MA of $14.48.
WuXi PharmaTech Cayman Inc. provides pharmaceutical and biotechnology research and development outsourcing. The Company's services include discovery chemistry, service biology, analytical, pharmaceutical development, and manufacturing.